News
Phase 3 data support “changing the current standard of care to now include neoadjuvant and adjuvant pembrolizumab,” according to Ravindra Uppaluri, MD, PhD.
Head and neck cancers, encompassing growths in the throat, larynx, nose, and mouth, account for 4% of cancers worldwide. Key ...
Talking to loved ones about a recent head and neck cancer diagnosis can be overwhelming. Of course, there is no one "right" ...
Proper nutrition is important for people diagnosed with cancer, both to help them feel better and to assist them in ...
Head and neck cancers are among the most difficult to treat. They can be aggressive and are located near some of the body's ...
Addition of neoadjuvant and adjuvant pembrolizumab to standard care significantly improves event-free survival.
6d
News Medical on MSNUnderstanding resistance to EGFR targeted therapies in head and neck cancers and breast cancerA new review was published in Volume 16 of Oncotarget on June 25, 2025, titled "Challenges and resistance mechanisms to EGFR ...
Head and neck cancer is a term that covers a range of cancers that can have a big impact on everyday life.Here are 6 important things to know.1. What ...
Head and neck cancers arise in the nasal cavity, sinuses, lips, mouth, salivary glands, throat or larynx. As per the National ...
Head and neck cancer arises in the mucosal epithelium, most often in the oral cavity, followed by the larynx and pharynx.
The oncologists cited several global studies that stated the link between oral health and cancer, particularly in head and neck cancers (HNC) ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results